Select Countries

00
Select All
Clear All
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central African Republic
Chad
Comoros
Congo
Côte d’Ivoire
Djibouti
DRC
Egypt
Equatorial Guinea
Eritrea
Eswatini
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
SADR
São Tomé and Príncipe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Tanzania
Togo
Tunisia
Uganda
Zambia
Zimbabwe

Select Indicators

Clear All
00
Maternal, Newborn, Child and Adolescent Health
Life expectancy at birth
Maternal mortality ratio
Stillbirth rate
Neonatal mortality rate
Infant mortality rate
Under 5 mortality rate
Antenatal care coverage: 4+ visits
Antenatal care coverage: 8+ visits
Births attended by skilled health personnel
Postpartum care coverage for mothers
Postnatal care coverage for newborns
Exclusive breastfeeding for infants under 6 months
Coverage of first dose of measles vaccination
Stunting - short height for age under age 5
Wasting – low weight for height under age 5
Overweight - heavy for height under 5
Sexual and Reproductive Health
Child marriage before age 15
Child marriage before age 18
Female genital mutilation
Sexual violence by age 18 - female
Sexual violence by age 18 - male
Very early child bearing under age 16
Adolescent birth rate ages 15 to 19
Contraceptive prevalance rate, modern methods, all women
Demand satisfied for modern contraception
Communicable Diseases
New HIV infections
Antiretroviral treatment coverage
Preventing mother-to-child transmission of HIV
Condom use
New TB infections
New malaria infections
Non-Communicable Diseases
Mortality from non-communicable diseases
Suicide mortality rate
Current tobacco use among females aged 15 and over
Current tobacco use among males aged 15 and over
Harmful alcohol use aged 15 and over
Health Financing
Health systems and policies
Density of health workers - physicians
Density of health workers - nurses and midwives
Density of health workers - pharmaceutical staff
Qualified obstetricians
Birth registration
At least basic drinking water
At least basic sanitation services
Open defecation
Implementation of AMRH Initiative

Create Chart

 

 
 

Your Selection

Countries:
Indicators:
  • None selected
  • None selected

Indicator Title

Return

Indicator Information

Select Stats

Contact

Alphabetical order

Download
Print
What does it mean ?
Full Name:Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of mother-to-child transmission of HIV
Full Unit: Percentage, %
Year-range of Data:2017
Source:UNAIDS AIDSinfo
Link to Source:http://aidsinfo.unaids.org/
Date Source Published:July 2018
Date Source Accessed:31st January 2019

The following countries had no data:
Cape Verde, Central African Republic, Comoros, DRC, Libya, Mauritius, Nigeria, SADR, São Tomé and Príncipe, Seychelles

Alternative Data Sources
   

Preventing mother-to-child transmission of HIV

What does it mean ?

The indicator measures the percentage of pregnant women living with HIV who received antiretroviral medicine among the estimated number of pregnant women living with HIV, to reduce the risk of mother-to-child transmission (PMTCT) of the virus.

Why does it matter ?

Providing antiretroviral medicines (as lifelong therapy or as prophylaxis) for the mother during pregnancy and delivery can significantly reduce the risk of mother-to-child transmission. This indicator allows countries to monitor the coverage of provision of antiretroviral medicines to pregnant women living with HIV to reduce the risk of transmitting HIV to infants during pregnancy and delivery. Since the indicator usually measures the antiretroviral medicines dispensed and not those consumed, adherence to the regimen cannot be determined in most cases. This entails antiretroviral medicine prophylaxis for the infant and antiretroviral medicines for the mother or child if breastfeeding and using safe delivery practices and safer infant feeding. The data will be used to track progress towards global and national goals of eliminating mother-to-child transmission; to inform policy and strategic planning; for advocacy; and for leveraging resources for accelerating scale-up.

How is it collected ?

Two pieces of information are needed: 1) number of pregnant women living with HIV who gave birth and received antiretroviral medicine during the past 12 months and 2) estimated number of pregnant women living with HIV who gave birth during the past 12 months. The first is obtained from monitoring tools used by programmes, such as patient registers and summary reporting forms. The second from surveys used for the surveillance of antenatal clinics in conjunction with demographic data, or estimation models such as Spectrum. Using these two estimates, the indicator is calculated by dividing the number of HIV-positive pregnant women who received antiretrovirals in the past 12 months by the number of HIV-positive pregnant women in the past 12 months.

Share this :

Close

More about indicator, sources and calculations

More about indicator and sources

This indicator allows countries to monitor the coverage of provision of antiretroviral medicines to pregnant women living with HIV to reduce the risk of transmitting HIV to infants during pregnancy and delivery. Since the indicator usually measures the antiretroviral medicines dispensed and not those consumed, adherence to the regimen cannot be determined in most cases.

Figures which are reported as > 95% for this indicator on the UNAIDS AIDSinfo database are shown on this African Health Stats platform as 95% for the following countries: Benin (2016); Botswana (2010, 2011, 2013, 2015, 2016); Cape Verde (2015, 2016, 2017); Eswatini (2011, 2014); Gamiba (2012); Guinea-Bissau (2014); Lesotho (2011); Namibia (2017); South Africa (2014,2016, 2017); Uganda (2014-2017); Tanzania (2012); Zambia (2010, 2011) and Zimbabwe (2017). Where the value was reported as <1% on the UNAIDS AIDSinfo database in Somalia (2010) is shown on AHStats as 0.9%.

For more information, download the Global AIDS Response Progress Report 2017: http://www.unaids.org/en/resources/documents/2017/2017_data_book [/ link]

More information on calculations

The numerator for this indicator is estimated number of women living with HIV who delivered within the past 12 months. For the numerator, the method of measurement from national programme records aggregated from programme monitoring tools, such as patient registries and summary reporting forms.

The denominator for this indicator is the number of pregnant women living with HIV who delivered during the past 12 months and received antiretroviral medicines to reduce the risk of the mother-to-child transmission of HIV. Global reports summarizing the coverage of antiretroviral medicine for preventing mother-to-child transmission will exclude women who received single-dose nevirapine, since it is considered a suboptimal regimen. However, the country should report the number of women who only received single-dose nevirapine. For the denominator, estimation models such as Spectrum or antenatal clinic surveillance surveys combined with demographic data and appropriate adjustments related to the coverage of antenatal clinic surveys.

See also the UNAIDS website on HIV data and estimates, including information on methodology, visit:

https://www.unaids.org/sites/default/files/media_asset/2017-Global-AIDS-Monitoring_en.pdf

CARMMA African Union

This site is managed by the African Union's Department of Social Affairs

Language:

English

French

Contact Us

Keep up to date:

Twitter

Facebook